Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
205 participants
INTERVENTIONAL
2013-06-13
2014-03-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ibuprofen Versus Placebo For Muscle Soreness
NCT03228992
5% Topical Ibuprofen (IBU) for Ankle Sprain
NCT01945034
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
NCT02113566
Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness
NCT02339129
Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)
NCT02597634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ibuprofen 5% topical gel BID
IBU BID (Treatment A)
IBU BID
10-cm strip of IBU 5% topical gel applied to the affected area BID (twice daily) x 3 days
Placebo topical gel BID
Placebo BID (Treatment B)
Placebo BID
10-cm strip of placebo topical gel applied to the affected area BID (twice daily) x 3 days
Ibuprofen 5% topical gel TID
IBU TID (Treatment C)
IBU TID
10-cm strip of IBU 5% topical gel applied to the affected area TID (three times daily) x 3 days
Placebo topical gel TID
Placebo TID (Treatment D)
Placebo TID
10-cm strip of placebo topical gel applied to the affected area TID (three times daily) x 3 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IBU BID
10-cm strip of IBU 5% topical gel applied to the affected area BID (twice daily) x 3 days
Placebo BID
10-cm strip of placebo topical gel applied to the affected area BID (twice daily) x 3 days
IBU TID
10-cm strip of IBU 5% topical gel applied to the affected area TID (three times daily) x 3 days
Placebo TID
10-cm strip of placebo topical gel applied to the affected area TID (three times daily) x 3 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Applied Pharmaceutical Research
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B3491010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.